Neuronetics (STIM) EBIAT (2017 - 2025)
Neuronetics (STIM) has disclosed EBIAT for 9 consecutive years, with -$9.0 million as the latest value for Q3 2025.
- On a quarterly basis, EBIAT rose 32.2% to -$9.0 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$44.2 million, a 21.45% decrease, with the full-year FY2024 number at -$43.7 million, down 44.78% from a year prior.
- EBIAT was -$9.0 million for Q3 2025 at Neuronetics, up from -$9.8 million in the prior quarter.
- In the past five years, EBIAT ranged from a high of -$4.9 million in Q2 2023 to a low of -$13.3 million in Q3 2024.
- A 5-year average of -$9.1 million and a median of -$9.0 million in 2025 define the central range for EBIAT.
- Peak YoY movement for EBIAT: crashed 138.47% in 2021, then skyrocketed 52.97% in 2023.
- Neuronetics' EBIAT stood at -$7.6 million in 2021, then fell by 8.56% to -$8.3 million in 2022, then surged by 35.14% to -$5.4 million in 2023, then tumbled by 135.48% to -$12.7 million in 2024, then increased by 28.57% to -$9.0 million in 2025.
- Per Business Quant, the three most recent readings for STIM's EBIAT are -$9.0 million (Q3 2025), -$9.8 million (Q2 2025), and -$12.7 million (Q1 2025).